SCHEMBL18308603

SCHEMBL18308603

c1ccc2c(-c3nc(-c4ccc(-c5nc6ccccc6s5)cc4)nc4ccccc34)cccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 8/20 0.49
▸ KDM4E B2RXH2 6/20 0.49
▸ NPC1 O15118 6/20 0.49
▸ APP P05067 5/20 0.49
▸ MAPT P10636 5/20 0.49
▸ MMP9 P14780 3/20 0.49
▸ MMP8 P22894 3/20 0.49
▸ GAA P10253 3/20 0.49
▸ ALDH1A1 P00352 3/20 0.49
▸ GLA P06280 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ PKM P14618 1/20 0.46
▸ PAX8 Q06710 1/20 0.46
▸ NOD2 Q9HC29 1/20 0.46
▸ TNF P01375 1/20 0.46
▸ NOD1 Q9Y239 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18308633 0.90 KDM4E (0.50) RAB9AKDM4ENPC1APPMAPT
SCHEMBL27284413 0.89 RAB9A (0.46) RAB9AKDM4ENPC1APPMAPT
SCHEMBL18308611 0.85 MEN1 (0.60) RAB9AKDM4ENPC1APPMAPT
SCHEMBL29202871 0.84 RAB9A (0.59) RAB9AKDM4ENPC1APPMAPT
SCHEMBL25896874 0.84 RAB9A (0.50) RAB9AKDM4ENPC1APPMAPT
SCHEMBL25861978 0.83 APP (0.50) RAB9AKDM4ENPC1APPMAPT
SCHEMBL25896393 0.83 RAB9A (0.47) RAB9AKDM4ENPC1APPMAPT
SCHEMBL25896748 0.83 RAB9A (0.47) RAB9AKDM4ENPC1APPMAPT
SCHEMBL23099273 0.83 APP (0.59) RAB9AKDM4ENPC1APPMAPT
SCHEMBL18308613 0.82 APP (0.49) RAB9AKDM4ENPC1APPMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3436452-B1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF DOW GLOBAL TECHNOLOGIES LLC (US) 2023-09-13 — — EP disclosed
US-11316114-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same Rohm and Haas Erlectronic Materials Korea Ltd. 2022-04-26 — — US disclosed
WO-2016197353-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DOW GLOBAL TECHNOLOGIES LLC (US) 2016-12-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11316114-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same EML4, ELAVL1, ELAVL3 RAB9A 1529/4885KDM4E 1041/4885NPC1 1650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback